Increased myeloperoxidase plasma levels in rheumatoid arthritis

Rheumatology International

Volumn 32, Issue 6, 2012, Pages 1605-1609

  Fernandes, Raissa Maria Sampaio Neves ^a   Da Silva, Neusa Pereira ^b   Sato, Emília Inoue ^b  

^a Brazilian Society of Rheumatology   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Disease activity; Myeloperoxidase; Rheumatoid arthritis

Indexed keywords

CHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; AGGLUTINATION TEST; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MYELOPEROXIDASE BLOOD LEVEL; OUTPATIENT CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BRAZIL; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LATEX FIXATION TESTS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PEROXIDASE; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84863874576     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1810-5     Document Type: Article

References (19)

1. Turesson C, Matteson EL (2006) Genetics of rheumatoid arthritis. Mayo Clin Proc 81(1):94-101
2. Malech HL, Gallin J (1987) Neutrophils in human diseases. N Engl J Med 317:687-694
3. Lefkowitz DL, Mills K, Lefkowitz SS, Bollen A, Moguilevsky N (1995) Neutrophil-macrophage interaction: a paradigm for chronic inXammation. Med Hypotheses 44:58-62
4. Lefkowitz DL, Lefkowitz SS (2001) Macrophage-neutrophil interaction: a paradigm for chronic inXammation revisited. Immunol Cell Biol 79:502-506
5. Brennan M-L, Penn MS, Van Lent F et al (2003) Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:1595-1604
6. Torsteinsdóttir I, Hakansson L, Hällgren R, Gudbjörnsson B, Arvidson NG, Venge P (1999) Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis. Rheumatology (Oxford) 38:1249-1254
7. Milovanovic M, Nilsson E, Järemo P (2004) Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 343:237-240
8. Minohara M, Matsuoka T, Li W et al (2006) Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol 178: 156-160
9. Baskol G, Demir H, Baskol M et al (2006) Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Funct 24:307-311
10. Accardo-Palumbo A, Triolo G, Carbone MC et al (2000) Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease. Clin Exp Rheumatol 18:495-498
11. Baldus S, Heeschen C, Meinertz T et al (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108:1440-1445
12. Arnet FC, Edworthy SM, Bloch DA et al (1988) The American rheumatism association 1987 revised criteria for the classiWcation of rheumatoid arthritis. Arthritis Rheum 31:315-324
13. Prevoo ML, Van Gestel AM, Van't Hof MA, Van Rijswijk MH, Van de Putte LB, Van Riel PL (1996) Remission in a prospective study of patients with rheumatoid arthritis. American rheumatism association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 35:1101-1105
14. Prevoo MLL, Van't Hof MA, Van Leeuwen MA, Pute LB, Van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44-48
15. Van Gestel AM, Haagsma CJ, van Riel PLCM (1998) Validation of rheumatoid arthritis improvement criteria that includes simpli-Wed joint counts. Arthritis Rheum 41:1845-1850
16. Costa D, Moutinho L, Lima JLFC, Fernandes E (2006) Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non-steroidal anti-inflammatory drugs. Biol.Pharm. Bull 29:1659-1670
17. Wildfeuer A (1984) EVect of anti-rheumatic drugs on the release of lysosomal enzymes from human leukocytes. Z Rheumatol 43:23-26
18. Lau D, Mollnau H, Eiserich JP et al (2005) Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci 102(2):431-436
19. Telles RW, Ferreira GA, Silva NP, Sato EI (2010) Increased plasma myeloperoxidase levels in systemic lupus erythematosus. Rheumatol Int 30:779-784